Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vadim Kostousov

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Clinics in Laboratory Medicine|May 15, 2026
Updates on Use and Monitoring of Direct Thrombin InhibitorsAmir Navaei, Vadim Kostousov, Jun Teruya
Frontiers in Medicine|September 6, 2023
Is it time to switch to bivalirudin for ECMO anticoagulation?Amir Navaei, Vadim Kostousov, Jun Teruya
Archives of Pathology & Laboratory Medicine|December 29, 2023
Bivalirudin Stability in Citrated Plasma and Citrated Whole BloodKaren Bruzdoski, Vadim Kostousov, Jun Teruya
Seminars in Thrombosis and Hemostasis|September 13, 2017
Bleeding and Thrombotic Complications in the Use of Extracorporeal Membrane OxygenationJames Thomas, Vadim Kostousov, Jun Teruya
Thrombosis Research|January 25, 2006
Novel, semi-automated, 60-min-assay to determine von Willebrand factor cleaving activity of ADAMTS-13Vadim Kostousov, Jörg Fehr, Thomas Bombeli
Archives of Pathology & Laboratory Medicine|October 31, 2014
The influence of free hemoglobin and bilirubin on heparin monitoring by activated partial thromboplastin time and anti-Xa assayVadim Kostousov, Kim Nguyen, Shilpa G Hundalani, et al.
International Journal of Laboratory Hematology|December 23, 2021
How to best monitor bivalirudin anticoagulant effect for ECMO and VAD-Comparison of four assay methodsJun Teruya, Karen Bruzdoski, Lisa Hensch, et al.
Seminars in Thrombosis and Hemostasis|November 23, 2017
Management of Hemostasis for Pediatric Patients on Ventricular-Assist DevicesIki Adachi, Vadim Kostousov, Lisa Hensch, et al.
International Journal of Laboratory Hematology|August 20, 2020
C-reactive protein-induced activated partial thromboplastin time prolongation in heparinized samples is attenuated by elevated factor VIIIVadim Kostousov, Sridevi Devaraj, Karen Bruzdoski, et al.
Thrombosis Research|December 30, 2019
Monitoring bivalirudin therapy in children on extracorporeal circulatory support devices: Thromboelastometry versus routine coagulation testingJun Teruya, Lisa Hensch, Karen Bruzdoski, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Clinics in Laboratory Medicine|May 15, 2026
Updates on Use and Monitoring of Direct Thrombin InhibitorsAmir Navaei, Vadim Kostousov, Jun Teruya
Frontiers in Medicine|September 6, 2023
Is it time to switch to bivalirudin for ECMO anticoagulation?Amir Navaei, Vadim Kostousov, Jun Teruya
Archives of Pathology & Laboratory Medicine|December 29, 2023
Bivalirudin Stability in Citrated Plasma and Citrated Whole BloodKaren Bruzdoski, Vadim Kostousov, Jun Teruya
Seminars in Thrombosis and Hemostasis|September 13, 2017
Bleeding and Thrombotic Complications in the Use of Extracorporeal Membrane OxygenationJames Thomas, Vadim Kostousov, Jun Teruya
Thrombosis Research|January 25, 2006
Novel, semi-automated, 60-min-assay to determine von Willebrand factor cleaving activity of ADAMTS-13Vadim Kostousov, Jörg Fehr, Thomas Bombeli
Archives of Pathology & Laboratory Medicine|October 31, 2014
The influence of free hemoglobin and bilirubin on heparin monitoring by activated partial thromboplastin time and anti-Xa assayVadim Kostousov, Kim Nguyen, Shilpa G Hundalani, et al.
International Journal of Laboratory Hematology|December 23, 2021
How to best monitor bivalirudin anticoagulant effect for ECMO and VAD-Comparison of four assay methodsJun Teruya, Karen Bruzdoski, Lisa Hensch, et al.
Seminars in Thrombosis and Hemostasis|November 23, 2017
Management of Hemostasis for Pediatric Patients on Ventricular-Assist DevicesIki Adachi, Vadim Kostousov, Lisa Hensch, et al.
International Journal of Laboratory Hematology|August 20, 2020
C-reactive protein-induced activated partial thromboplastin time prolongation in heparinized samples is attenuated by elevated factor VIIIVadim Kostousov, Sridevi Devaraj, Karen Bruzdoski, et al.
Thrombosis Research|December 30, 2019
Monitoring bivalirudin therapy in children on extracorporeal circulatory support devices: Thromboelastometry versus routine coagulation testingJun Teruya, Lisa Hensch, Karen Bruzdoski, et al.
Pageof 3